Cerus reported $95.02M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Atrion ATRI:US USD 19.27M 5.93M
Cerus CERS:US USD 95.02M 15.74M
Cytori Therapeutics CYTX:US USD 7.42M 449K
Haemonetics HAE:US USD 262.18M 81.69M
Meridian Bioscience VIVO:US USD 57.95M 2.4M
Neogen NEOG:US USD 152.56M 85.55M
Nuvasive NUVA:US USD 697.4M 3.95M
Orasure Technologies OSUR:US USD 71.7M 6.21M
Quidel QDEL:US USD 872.7M 27.3M
Rockwell Medical RMTI:US USD 19.34M 803K
Sientra SIEN:US USD 81.2M 3.18M
Staar Surgical STAA:US USD 45.32M 1.19M
Terumo 4543:JP JPY 202.26B 18.8B
Utah Medical Products UTMD:US USD 6.27M 1.83M